| Sep 3 2014 |
Nonprofit Hospital Revenue Growth Slows |
Sheppard, Mullin, Richter & Hampton LLP |
| Sep 3 2014 |
The Affordable Care Act—Countdown to Compliance for Employers, Week 17: Cherry Bomb in the Gold Fish Pond, or Third-Party Staffing Arrangements and “Offers of Coverage by Unrelated Employers” |
Mintz |
| Sep 3 2014 |
EEOC Lawsuit Targets Employee Wellness Programs |
Godfrey & Kahn S.C. |
| Sep 3 2014 |
China Allows Wholly Foreign-Owned Hospitals in Seven Pilot Cities and Provinces |
McDermott Will & Emery |
| Sep 3 2014 |
Government Issues New Rules for Religious Employers, But Health Plans, Third Party Administrators (TPAs), and Pharmacy Benefits Managers (PBMs) are still on the Hook to Provide Contraceptive Coverage |
Mintz |
| Sep 2 2014 |
EU Court Of Justice Further Clarifies Definition Of Medicinal Products – And Raises New Questions |
Covington & Burling LLP |
| Sep 2 2014 |
China Issues Multiple Final Rules and Proposals to Implement Recent Revisions to its Core Medical Device Regulation |
Covington & Burling LLP |
| Sep 2 2014 |
Medicare Pioneer Accountable Care Organization (ACO): Another Pioneer Leaves The West |
Sheppard, Mullin, Richter & Hampton LLP |
| Sep 2 2014 |
Summary of FDA Advertising and Promotion Enforcement Activities – September 2, 2014 |
Covington & Burling LLP |
| Sep 2 2014 |
The Increasingly Murky World of 340B Drug Discount Program: What’s Next? |
Mintz |
| Sep 2 2014 |
Two-Party Market: Presumption of Confusion and Injury |
McDermott Will & Emery |
| Sep 1 2014 |
EEOC Sues Arthur’s Restaurant & Bar for Pregnancy Discrimination |
U.S. Equal Employment Opportunity Commission |
| Aug 30 2014 |
Opinion Underlying Judgment as a Matter of Law (JMOL) May Still Provide Basis for a New Trial, Even if JMOL Is Defective |
McDermott Will & Emery |
| Aug 29 2014 |
Physician Compensation under Medicaid |
Giordano, Halleran & Ciesla, P.C. |
| Aug 29 2014 |
“Medicaid: Getting Paid and Keeping It”: A Recap of Part II of the Webinar |
McBrayer, McGinnis, Leslie and Kirkland, PLLC |
| Aug 29 2014 |
Pharmacies Avoid False Claims Act Suit: Fox Rx Inc. v. Omnicare Inc. et al. |
Covington & Burling LLP |
| Aug 28 2014 |
Veterans Affairs (VA) and Department of Defense (DOD) Announce New IT Contracting Opportunities |
Covington & Burling LLP |
| Aug 28 2014 |
Third Circuit Joins Second Circuit In Rejecting Vague Pleadings of FLSA Violations |
Jackson Lewis P.C. |
| Aug 28 2014 |
Health Care Industry Familiar with HIPAA Breaches, Not So Much Hackers |
McBrayer, McGinnis, Leslie and Kirkland, PLLC |
| Aug 27 2014 |
Wearable Devices and Data Privacy: Wearing Your Heart (Rate…and More) on Your Sleeve |
Morgan, Lewis & Bockius LLP |
| Aug 27 2014 |
Oregon City Mandates Paid Sick Leave but County Wants Status Quo |
Jackson Lewis P.C. |
| Aug 27 2014 |
Important HIPAA Deadline and Privacy Updates |
Faegre Drinker |
| Aug 27 2014 |
New York Proposes Revised Regulations for Health Care Collaborations |
McDermott Will & Emery |
| Aug 27 2014 |
Another Court Weighs in on Rule 9(b)’s Requirements Under the False Claims Act |
Mintz |
| Aug 26 2014 |
Recent HIPAA Breaches Highlight Need for Providers to Remain Vigilant |
Godfrey & Kahn S.C. |
| Aug 26 2014 |
Health Care Law Update - August 25, 2014 |
Mintz |
| Aug 26 2014 |
Carondelet Health Network To Pay $35 million To Settle Federal Health Care Billing Fraud Case; Whistleblower To Receive $6 million |
Tycko & Zavareei LLP |
| Aug 26 2014 |
PA Federal Courts Analyze Pennsylvania Human Relations Act (PHRA) Disability Claims Under Pre-ADAAA Standards |
Steptoe & Johnson PLLC |
| Aug 26 2014 |
Bundled Discounts Subject to Section 1/Clayton 3 Scrutiny In the Absence of Market Power and Substantial Foreclosure? |
Sheppard, Mullin, Richter & Hampton LLP |
| Aug 25 2014 |
Look Beyond the ACA Wellness Regulations When Designing Your Program, EEOC Sues Employer Over Its Program |
Jackson Lewis P.C. |
| Aug 25 2014 |
FDA Notifies Congress of Framework for Long-Awaited Guidance on Laboratory Developed Tests and Issues Final Guidance on Companion Diagnostics |
Mintz |
| Aug 25 2014 |
FDA Issues Draft Guidance on De Novo Process |
Barnes & Thornburg LLP |
| Aug 25 2014 |
Medical Device Update: FDA Issues Draft Guidance on Streamlined De Novo Classification Process |
Morgan, Lewis & Bockius LLP |
| Aug 25 2014 |
Prescription Drugs: Refocusing the False Claims Act Microscope on the Rest of the Transaction |
Mintz |
| Aug 25 2014 |
Physicians Write Letter to FDA Regarding Biosimilar Naming Concerns |
McDermott Will & Emery |
